Table 2.
Adverse events related to vaccine and IL-2
Vaccine-related AEs | Maximum Grade | Patients | ||
System | Adverse Events | N = 25 | % | |
Constitutional | Fever | 1 | 8 | 32 |
Pain at injection site | 1 | 4 | 16 | |
Injection site reaction | 1 | 3 | 12 | |
Myalgia | 1 | 1 | 4 | |
Chills | 1 | 1 | 4 | |
IL-2-related AEs | ||||
Cardiovascular | Cardiopulmonary arrest | 4 | 1 | 4 |
Elevated troponin | 4 | 1 | 4 | |
Hypotension | 4 | 9 | 36 | |
Ventricular tachycardia | 3 | 1 | 4 | |
Acidosis | 4 | 1 | 4 | |
Electrolyte | Hyperglycemia | 3 | 4 | 16 |
Hypocalcemia | 3 | 1 | 4 | |
Hyponatremia | 3 | 11 | 44 | |
Hypophosphatemia | 3 | 3 | 12 | |
Gastro-intestinal | Ischemic bowel | 4 | 1 | 4 |
Hematologic | Anemia | 3 | 2 | 8 |
Neutropenia | 3 | 1 | 4 | |
Thrombocytopenia | 3 | 4 | 16 | |
Hepatic | Elevated transaminases | 3 | 1 | 4 |
Hyperbilirubinemia | 3 | 3 | 12 | |
Neurologic | Confusion | 3 | 3 | 12 |
Syncope | 3 | 2 | 8 | |
Pulmonary | Dyspnea | 3 | 1 | 4 |
Renal | Elevated creatinine | 3 | 22 | 88 |
Oliguria | 3 | 2 | 8 | |
Systemic | Fatigue | 3 | 1 | 4 |